People · Operator
Named in public records as an officer, director or promoter · active 2018–2025 · Biotechnology, Other Health Care, Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Normunity Holding Company, LLC | — | Biotechnology | Series C | $83.4M | $273.2M | 2025 |
| Urgent Specialists Management, LLC | — | Other Health Care | Series A | $10.0M | $201.8M | 2018 |
| Sedare Biosciences, Inc. | — | Biotech / Pharma | Seed | $2.5M | $15.5M | 2024 |
David Parry at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Parry on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Timothy Shannon | 1 | 9 |
| Sakae Asanuma | 1 | 6 |
| Paulina Hill | 1 | 5 |
| Scott Phillips | 1 | 5 |
| Sara Nayeem | 1 | 4 |
| Jason Levine | 1 | 4 |
| Donald McCarthy | 1 | 3 |
| Darlene Deptula-Hicks | 1 | 3 |
| Rachel Humphrey | 1 | 2 |
| John Webster | 1 | 2 |
| Marie-Claire Peakman | 1 | 2 |
| ROBERT DEAN | 1 | 2 |
| Christian Richard | 1 | 2 |
| Timothy Dixon | 1 | 1 |
| Debanian Ray | 1 | 1 |
| Yunxia Yang | 1 | 1 |
| James Trenkle | 1 | 1 |
| Ravichandran Rao | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.